Research

#Lipids #mRNA #Research

eTheRNA expands R&D capacity   

mRNA technology discovery and development company, eTheRNA immunotherapies has announced it has relocated its R&D group to a larger site in Belgium.   The company has moved its R&D facility to the Zwijnaarde Science Park in Gent, Belgium, which features a cluster of biotech companies and includes laboratories… Read More

#News

Woman reaches for inhaler
#Asthma #Data #Research

40% of asthma patients overusing inhalers, says data 

New results from an observational data analysis of asthma inhaler therapy found that short-acting beta2-agonist (SABA) reliever overuse is a global issue adversely impacting asthma outcomes.1,2   Data from across the SABA Use IN Asthma (SABINA) global programme have been published in The Journal of Allergy… Read More

#News #Trending News

#Covid-19 #Drug discovery #Research

Experts evaluate the effects of ACE2-mediated Covid-19 infection 

Bachem, a Swiss technology company active in the fields of chemistry, biochemistry and pharmaceuticals, as well as the development and production of peptides and oligonucleotides, analyses the findings from scientific research about the relationship between ACE2 and SARS-CoV-2.   Covid-19 has impacted almost everyone’s lives, whether through personal experience of infection… Read More

#Covid-19 #Exclusive Content #News

#Immunology / Virology & Vaccines #Research #Vaccine candidate

Research shows social media can improve vaccination rates 

New research from the International Longevity Centre (ILC) in London, UK, finds that social media advertising can be a cost-effective way of engaging older people in deprived communities with vaccination.  The approach  In the past, researchers found that older people are less likely to use… Read More

#News #Trending News

#Biomedical research #Data #Research

Spotlight: Tackling the issue of scientific data waste 

More than half of all scientific research is irreproducible, and more than 80% of scientific research data is being lost within 20 years. In the biomedical field alone, irreproducible research costs the industry £28 billion (US$38 billion) every year. Megan Thomas talks to Founder of Labstep Jake Schofield, about this issue.  MT:… Read More

#Business & Investment #Editor's Choice #Exclusive Content #Intelligence #News #Opinion #Start-up Zone #Trends & Analysis

#AI / data analytics / healthtech / informatics #Genetics #Research

New report helps provide accurate identification of variants in genes 

Researchers from National Institute of Standards and Technology (NIST), Baylor College of Medicine and DNAnexus, together with other members of the Genome in a Bottle (GIAB) consortium, have announced the publication of a comprehensive benchmark dataset comprising 273 challenging medically-relevant autosomal genes that are associated with the development of… Read More

#News

#Amino acids #Bacteria #Research

Scientists engineer bacteria for more robust biotechnologies 

Researchers from the Universities of Bristol and Hamburg have engineered bacteria with internal nutrient reserves that can be accessed when needed to survive extreme environmental conditions. The findings pave the way for more robust biotechnologies based on engineered microbes.  The challenge  Dr Thomas Gorochowski, joint… Read More

#News

#Autoimmune disease #Drug discovery #Research

Study profiles side-effects linked to common immunosuppressant 

New research led by scientists from the UK’s University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) has profiled the side effects of methotrexate – a common drug used to treat arthritis and other autoimmune diseases.   The findings  The authors hope their findings –… Read More

#News

#Collaboration #Drug delivery #Funding #Research

12 new grants for infectious disease and antimicrobial resistance 

The Bloomsbury SET – a knowledge exchange programme led by the UK’s Royal Veterinary College (RVC) – has announced a Commercialisation Pilot of 12 new grants for projects which will develop tools to better fight infectious disease or antimicrobial resistance (AMR). Supported by more than £1 million of funding, these projects will bring together researchers and businesses… Read More

#News

#Drug discovery #Infectious diseases #Molecular Biology #Research

Researchers discover way to disarm potentially deadly Listeria bacteria 

University of Queensland researchers have discovered a way to block Listeria from making the proteins that allow bacteria to survive and multiply in immune cells, which can cause severe illness in pregnant women and people with compromised immune systems. The study has been published in the journal PLOS Pathogens. Read More

#News

#Antibiotics #Drug development #Funding #Research

US researcher awarded $3.6 million to study antibiotic resistance

Sanford Burnham Prebys professor Andrei Osterman, Ph.D., has been awarded a $3.6 million grant from the National Institutes of Health (NIH) to expand current knowledge of antibiotic resistance, which will inform more precise antibiotic prescribing practices and help researchers develop drugs that are harder for bacteria to resist.   Context… Read More

#News

#Comment #Covid-19 #Genetics #Genomics #Public health #Research

Genomics boosts understanding of Covid-19 severity and susceptibility

Listen to this article on the DDW Podcast: The Covid-19 Host Genetics Initiative carried out one of the largest genome-wide association studies ever. It involved meta-analysis of nearly 50,000 Covid-19 patients and two million uninfected controls. Dr Hamdi Mbarek, Lead Analyst of the Qatari dataset explains how the initiative improved knowledge… Read More

#Covid-19 #Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Collaboration #Covid-19 #Mouse models #Research

Agreement paves the way for better mouse models to study Covid-19 

Scientists at La Jolla Institute for Immunology (LJI) and Charles River Laboratories International are launching a new project to uncover how different cells in the human immune system respond to SARS-CoV-2, the virus that causes Covid-19.   The research  This new mouse model has been engineered… Read More

#Covid-19 #News

#AI / data analytics / healthtech / informatics #Biotechnology #Database #Drug development #R&D #Research

Bridging the gap between R&D teams in biotechnology   

Ashu Singhal, President & Co-Founder of Benchling, shares newly heightened expectations for the biotechnology industry following the developments of the last 18 months.   The last 18 months have heightened expectations for the biotechnology industry. Scientists came together to develop vaccines at record speeds and set the… Read More

#News

#Biologics #Biotechnology #Pharmaceuticals #Research

Sino Biological establishes new location in Texas 

Sino Biological, provider of biological research reagents and related technical contract research services, has expanded to a new location in Houston, Texas.  The company has headquarters in Beijing, China and subsidiaries in Suzhou (China), Taizhou (China), Frankfurt (Germany), and Wayne (Pennsylvania, US). The new location in Houston allows for… Read More

#News

#Funding #Immunology / Virology & Vaccines #Life sciences #Research

£50m funding for new vaccine research building at Oxford University 

Oxford University has announced a £50 million funding commitment from Serum Life Sciences to establish The Poonawalla Vaccines Research Building at the University of Oxford.  What will it do?  The Poonawalla Vaccines Research Building will share infrastructure and support facilities with Oxford University Pandemic Sciences… Read More

#News